Scholarlink

Purpose <p>To highlight the risk factors contributing to blood transfusion among patients undergoing surgical intervention for Stage I Endometrial Cancer (EC).</p> Method <p>Using the American College of Surgeons National Surgical Quality Improvement Program database, a nationally validated database dedicated to improving surgical care, females over the age of 18 who underwent surgery for EC stage I between the years 2016–2022 were queried. The cohort was then characterized based on those who received blood transfusion 72&#xa0;h postoperatively.</p> Results <p>27,183 patients with endometrial cancer who received surgical management were identified. 668 (2.5%) of those patients received blood transfusions. A multivariate logistic model found that a medical factor low preoperative Hct % (aOR 22.4, 95% CI[17.7, 28.3]; <i>p</i> &lt; 0.001) and surgical factors such as 180&#xa0;min or more of operative time (aOR 3.38, 95% CI[2.77, 4.14]; <i>p</i> &lt; 0.001), larger uteri of 250–500&#xa0;g (aOR 1.93, 95% CI[1.48, 2.49]; <i>p</i> &lt; 0.001) and ≥ 500&#xa0;g (aOR 2.35, 95% CI[1.77, 3.12]; <i>p</i> &lt; 0.001), and abdominal approach compared to laparoscopic (aOR 6.36,95% CI[4.95, 8.18]; <i>p</i> &lt; 0.001) were significantly associated with receiving blood transfusion.</p> Conclusion <p>Many significant risk factors were found to be associated with blood transfusions in patients with Stage I endometrial cancer. These findings allow surgeons to proactively prepare adequate measures for patients who may require blood transfusions when they undergo surgery for endometrial cancer. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Risk factors for blood transfusion in patients undergoing hysterectomy for stage I endometrial cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月17日

查看全文
  • Abdelrahman Yousif,
  • Hatem S. Mohamed,
  • Anna Woodham,
  • Mohanad Elchouemi,
  • IIana Chefetz

摘要

Purpose

To highlight the risk factors contributing to blood transfusion among patients undergoing surgical intervention for Stage I Endometrial Cancer (EC).

Method

Using the American College of Surgeons National Surgical Quality Improvement Program database, a nationally validated database dedicated to improving surgical care, females over the age of 18 who underwent surgery for EC stage I between the years 2016–2022 were queried. The cohort was then characterized based on those who received blood transfusion 72 h postoperatively.

Results

27,183 patients with endometrial cancer who received surgical management were identified. 668 (2.5%) of those patients received blood transfusions. A multivariate logistic model found that a medical factor low preoperative Hct % (aOR 22.4, 95% CI[17.7, 28.3]; p < 0.001) and surgical factors such as 180 min or more of operative time (aOR 3.38, 95% CI[2.77, 4.14]; p < 0.001), larger uteri of 250–500 g (aOR 1.93, 95% CI[1.48, 2.49]; p < 0.001) and ≥ 500 g (aOR 2.35, 95% CI[1.77, 3.12]; p < 0.001), and abdominal approach compared to laparoscopic (aOR 6.36,95% CI[4.95, 8.18]; p < 0.001) were significantly associated with receiving blood transfusion.

Conclusion

Many significant risk factors were found to be associated with blood transfusions in patients with Stage I endometrial cancer. These findings allow surgeons to proactively prepare adequate measures for patients who may require blood transfusions when they undergo surgery for endometrial cancer.